Search Results - "Coupé, Veerle M. H"

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer by Uil, Sjoerd H, Coupé, Veerle M H, Bril, Herman, Meijer, Gerrit A, Fijneman, Remond J A, Stockmann, Hein B A C

“…The risk of recurrence after resection of a stage II or III colon cancer, and therefore qualification for adjuvant chemotherapy (ACT), is traditionally based…”
Get full text

A progressive three-state model to estimate time to cancer: a likelihood-based approach by Akwiwu, Eddymurphy U, Klausch, Thomas, Jodal, Henriette C, Carvalho, Beatriz, Løberg, Magnus, Kalager, Mette, Berkhof, Johannes, Coupé, Veerle M H

“…To optimize colorectal cancer (CRC) screening and surveillance, information regarding the time-dependent risk of advanced adenomas (AA) to develop into CRC is…”
Get full text

A scenario‐drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology by Kramer, Astrid, Rubio‐Alarcón, Carmen, Broek, Daan, Vessies, Daan C. L., van't Erve, Iris, Meijer, Gerrit A., Vink, Geraldine R., Schuuring, Ed, Fijneman, Remond J. A., Coupé, Veerle M. H., Retèl, Valesca P.

“…Circulating tumor DNA (ctDNA) detection has multiple promising applications in oncology, but the road toward implementation in clinical practice is unclear. We…”
Get full text

Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands by Mfumbilwa, Zakile A., Wilschut, Janneke A., Simons, Martijn J. H. G., Ramaekers, Bram, Joore, Manuela, Retèl, Valesca, der Welle, Christine M. Cramer-van, Schramel, Franz M. N. H., van de Garde, Ewoudt M. W., Coupé, Veerle M. H.

“…Recent discoveries in molecular diagnostics and drug treatments have improved the treatment of patients with advanced (inoperable) non-squamous non-small cell…”
Get full text

Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trial by Swartjes, Hidde, Qaderi, Seyed M, Teerenstra, Steven, Custers, Jose A. E, Elferink, Marloes A. G, van Wely, Bob J, Burger, Jacobus W. A, van Grevenstein, Wilhelmina M. U, van Duijvendijk, Peter, Verdaasdonk, Emiel G. G, de Roos, Marnix A. J, Coupé, Veerle M. H, Vink, Geraldine R, Verhoef, Cornelis, de Wilt, Johannes H. W

“…Abstract Background Colorectal cancer (CRC) is among the most frequently diagnosed cancers. Approximately 20–30% of stage I-III CRC patients develop a…”
Get full text

Modeling the Adenoma and Serrated Pathway to Colorectal CAncer (ASCCA) by Greuter, Marjolein J. E., Xu, Xiang-Ming, Lew, Jie-Bin, Dekker, Evelien, Kuipers, Ernst J., Canfell, Karen, Meijer, Gerrit A., Coupé, Veerle M. H.

“…Several colorectal cancer (CRC) screening models have been developed describing the progression of adenomas to CRC. Currently, there is increasing evidence…”
Get full text

Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study by van Lanschot, Meta C J, Carvalho, Beatriz, Coupé, Veerle M H, van Engeland, Manon, Dekker, Evelien, Meijer, Gerrit A

“…As in many other European countries, a nationwide screening program for colorectal cancer (CRC) has recently been introduced in the Netherlands. As a side…”
Get full text

Cost-effectiveness of different strategies for diagnosis of uncomplicated urinary tract infections in women presenting in primary care by Bosmans, Judith E, Coupé, Veerle M H, Knottnerus, Bart J, Geerlings, Suzanne E, Moll van Charante, Eric P, Ter Riet, Gerben

“…Uncomplicated Urinary Tract Infections (UTIs) are common in primary care resulting in substantial costs. Since antimicrobial resistance against antibiotics for…”
Get full text

Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials by Lew, Jie-Bin, Greuter, Marjolein J. E., Caruana, Michael, He, Emily, Worthington, Joachim, St John, D. James, Macrae, Finlay A., Feletto, Eleonora, Coupé, Veerle M. H., Canfell, Karen

“…Background. This study aimed to assess the validity of 2 microsimulation models of colorectal cancer (CRC), Policy1-Bowel and ASCCA. Methods. The…”
Get full text

Efficacy and cost-utility of the eHealth self-management application 'Oncokompas', helping partners of patients with incurable cancer to identify their unmet supportive care needs and to take actions to meet their needs: a study protocol of a randomized controlled trial by Schuit, Anouk S, Holtmaat, Karen, Hooghiemstra, Nienke, Jansen, Femke, Lissenberg-Witte, Birgit I, Coupé, Veerle M H, Verdonck-de Leeuw, Irma M

“…Incurable cancer does not only affect patients, it also affects the lives of their partners. Many partners take on caregiving responsibilities. The burden of…”
Get full text

Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial by van der Hout, Anja, van Uden-Kraan, Cornelia F, Witte, Birgit I, Coupé, Veerle M H, Jansen, Femke, Leemans, C René, Cuijpers, Pim, van de Poll-Franse, Lonneke V, Verdonck-de Leeuw, Irma M

“…Cancer survivors have to deal with a wide range of physical symptoms, psychological, social and existential concerns, and lifestyle issues related to cancer…”
Get full text

Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation? by Jansen, Femke, Coupé, Veerle M. H., Eerenstein, Simone E. J., Leemans, C. René, Verdonck-de Leeuw, Irma M.

“…Purpose The aim of this study is to investigate the associations between patient activation and total costs in cancer patients treated with total laryngectomy…”
Get full text

Long-term Impact of Human Papillomavirus Vaccination on Infection Rates, Cervical Abnormalities, and Cancer Incidence by Bogaards, Johannes A., Coupé, Veerle M. H., Xiridou, Maria, Meijer, Chris J. L. M., Wallinga, Jacco, Berkhof, Johannes

“…Background: Vaccination against human papillomavirus (HPV) types 16/18 is being implemented in many countries. There may be indirect benefit of HPV vaccination…”
Get full text

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study by den Uil, Sjoerd H, van den Broek, Evert, Coupé, Veerle M H, Vellinga, Thomas T, Delis-van Diemen, Pien M, Bril, Herman, Belt, Eric J Th, Kranenburg, Onno, Stockmann, Hein B A C, Belien, Jeroen A M, Meijer, Gerrit A, Fijneman, Remond J A

“…Microvessel density (MVD), as a derived marker for angiogenesis, has been associated with poor outcome in several types of cancer. This study aimed to evaluate…”
Get full text

Resilience of a FIT screening programme against screening fatigue: a modelling study by Greuter, Marjolein J E, Berkhof, Johannes, Canfell, Karen, Lew, Jie-Bin, Dekker, Evelien, Coupé, Veerle M H

“…Repeated participation is important in faecal immunochemical testing (FIT) screening for colorectal cancer (CRC). However, a large number of screening…”
Get full text

Cost-Utility of the eHealth Application ‘Oncokompas’, Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial by Schuit, Anouk S, Holtmaat, Karen, Coupé, Veerle M. H, Eerenstein, Simone E. J, Zijlstra, Josée M, Eeltink, Corien, Becker-Commissaris, Annemarie, van Zuylen, Lia, van Linde, Myra E, Menke-van der Houven van Oordt, C. Willemien, Sommeijer, Dirkje W, Verbeek, Nol, Bosscha, Koop, Nandoe Tewarie, Rishi, Sedee, Robert-Jan, de Bree, Remco, de Graeff, Alexander, de Vos, Filip, Cuijpers, Pim, Verdonck-de Leeuw, Irma M, Jansen, Femke

“…Evidence on the cost-effectiveness of eHealth in palliative care is scarce. Oncokompas, a fully automated behavioral intervention technology, aims to support…”
Get full text

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients by Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.

“…Background: We aimed to evaluate the cost-effectiveness of risk-based strategies to improve the selection of surgically treated stage II colon cancer (CC)…”
Get full text

Model-Based Estimation of Viral Transmissibility and Infection-Induced Resistance From the Age-Dependent Prevalence of Infection for 14 High-Risk Types of Human Papillomavirus by Bogaards, Johannes A., Xiridou, Maria, Coupé, Veerle M. H., Meijer, Chris J. L. M., Wallinga, Jacco, Berkhof, Johannes

“…Viral transmissibility and natural resistance to infection are key determinants in assessing the population impact of human papillomavirus (HPV) vaccination,…”
Get full text

Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer by Kramer, Astrid, Greuter, Marjolein J E, Schraa, Suzanna J, Vink, Geraldine R, Phallen, Jillian, Velculescu, Victor E, Meijer, Gerrit A, van den Broek, Daan, Koopman, Miriam, Roodhart, Jeanine M L, Fijneman, Remond J A, Retèl, Valesca P, Coupé, Veerle M H

“…Current patient selection for adjuvant chemotherapy (ACT) after curative surgery for stage II colon cancer (CC) is suboptimal, causing overtreatment of…”
Get full text

Efficacy and cost-utility of the eHealth application 'Oncokompas', supporting patients with incurable cancer in finding optimal palliative care, tailored to their quality of life and personal preferences: a study protocol of a randomized controlled trial by Schuit, Anouk S, Holtmaat, Karen, Hooghiemstra, Nienke, Jansen, Femke, Lissenberg-Witte, Birgit I, Coupé, Veerle M H, van Linde, Myra E, Becker-Commissaris, Annemarie, Reijneveld, Jaap C, Zijlstra, Josée M, Sommeijer, Dirkje W, Eerenstein, Simone E J, Verdonck-de Leeuw, Irma M

“…Patients with incurable cancer have to deal with a wide range of symptoms due to their disease and treatment, influencing their quality of life. Nowadays,…”
Get full text